# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001640334-22-000822
Filing Date
2022-04-20
Accepted
2022-04-20 11:20:37
Documents
24
Period of Report
2022-04-19
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | lxrp_8k.htm iXBRL | 8-K | 24058
2 | EX-99.1 | lxrp_ex991.htm | EX-99.1 | 5710
8 |  | lxrp_ex991img7.jpg | GRAPHIC | 127046
9 |  | lxrp_ex991img9.jpg | GRAPHIC | 202992
10 |  | lxrp_ex991img1.jpg | GRAPHIC | 232878
11 |  | lxrp_ex991img2.jpg | GRAPHIC | 245926
12 |  | lxrp_ex991img3.jpg | GRAPHIC | 291904
13 |  | lxrp_ex991img4.jpg | GRAPHIC | 372677
14 |  | lxrp_ex991img5.jpg | GRAPHIC | 153371
15 |  | lxrp_ex991img6.jpg | GRAPHIC | 167969
16 |  | lxrp_ex991img8.jpg | GRAPHIC | 104017
| Complete submission text file | 0001640334-22-000822.txt |  | 2769839

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | lxrp-20220419.xsd | EX-101.SCH | 5830
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | lxrp-20220419_lab.xml | EX-101.LAB | 14731
5 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | lxrp-20220419_cal.xml | EX-101.CAL | 898
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | lxrp-20220419_pre.xml | EX-101.PRE | 9356
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | lxrp-20220419_def.xml | EX-101.DEF | 2103
18 | EXTRACTED XBRL INSTANCE DOCUMENT | lxrp_8k_htm.xml | XML | 3601

Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 001-39874 | Film No.: 22836948
SIC: 2834 Pharmaceutical Preparations